Aging can cause the kidneys to take longer to clear medications and metabolize them
Can occur at both the patient level and the medical system level
“...poor medical record keeping can lead to polypharmacy if discontinued medications are not removed from the record and are refilled automatically or if a physician receives an automated refill request for a discontinued medication” (American Family Physician)
Fast Facts
83% of adults in their 60s and 70s in the United States have used at least one prescription drug in the last month and one-third has used five or more prescription drugs in the last month (CDC)
Patients taking five to nine medications have a 50% chance of an adverse drug interaction (US Pharmacist)
Patients have a 100% chance of an adverse drug interaction when they are taking 20 or more medications (US Pharmacist)
Polypharmacy accounts for almost 30% of all hospital admissions and is the fifth leading cause of death in the U.S. (US Pharmacist)
What are the risks?
Managing multiple medications can be difficult to track, hard to manage, and expensive
Can be a burden on the patient and family in order to understand each prescription, the provider, staying on top of refills, knowing the side effects for each medication, etc.
Taking multiple medications increases the risk of adverse reactions and/or drug interactions
Examples: falls, cognitive impairment, misdiagnoses, emergency room visits, etc.
Adults living in long-term care facilities are often at higher risk because they are typically more frail and have multiple medical issues
Younger adults with chronic conditions such as diabetes, heart, disease, and fibromyalgia may experience polypharmacy
Patients with mental health conditions are often prescribed several medications at once
Deprescribing
Discontinuing medications, decreasing dosage, changing medications, etc.
Recommended as a tool to reduce the risk of adverse reactions and financial difficulty
Challenges of deprescribing: time constraints, lack of support, patient resistance
Additional Questions for Dr. Chakolis
Are there disparities in polypharmacy among different populations? (i.e. race, gender, etc.)
Which drugs are most commonly used in polypharmacy?
And, which drugs are the leading “culprits” of adverse reactions in polypharmacy?